Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2025-02-25

Clinical Trial Update: Seocalcitol Versus Placebo in the Adjuvant Treatment of Hepatocellular Carcinoma [Phase 3]

View source ↗

Summary

The Phase 3 trial comparing Seocalcitol to placebo for adjuvant treatment of hepatocellular carcinoma has been terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Seocalcitol (EB1089)

Snippet

Sponsor: LEO Pharma | Conditions: Liver Neoplasms | Phase 3 | Status: TERMINATED